QA: ESSA Pharma Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001633932_2023_ESSA_Pharma_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001633932, ESSA Pharma Inc.

  xvar xval
0 AssetsCurrent 169,059,341
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 445,954
4 LiabilitiesCurrent 2,310,399
5 LiabilitiesNoncurrent 76,418
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 12,544,760
9 ResearchAndDevelopmentExpense 24,415,246
10 remainder_Expenses -98,075
11 remainder_Revenues 1,736,641
12 remainder_NetIncome 22,039
13 remainder_ComprehensiveNetIncome -58,666
  yvar yval
0 Assets 169,505,295
1 Liabilities 2,386,817
2 Expenses 36,861,931
3 Revenues 1,736,641
4 StockholdersEquity 167,118,478
5 NetIncome -35,103,251
6 ComprehensiveNetIncome -35,132,584
7 BaseVar 105,285,694
8 EconomicCapitalRatio 2.94

Edgar->Model Mapping

Feature Distribution

Change over Time